在失眠和动脉样硬化中探索共享的生物标志物和共享的途径,使用综合生物信息学分析
Qichong Yang1,2, Juncheng Liu2,3, Tingting Zhang4
1Central China Fuwai Hospital of Zhengzhou University, Fuwai Central China Cardiovascular Hospital, Zhengzhou, Henan, China.
Frontiers in molecular neuroscience
|October 23, 2024
概括
失眠与动脉样硬化有关. 这项研究确定了三个关键基因 (IL10RA,CCR1,SPI1) 作为失眠相关动脉样硬化症的诊断生物标志物,为早期检测和治疗提供了新的见解.
科学领域:
- 生物信息学是一种生物信息学.
- 基因组学就是基因组学.
- 心血管疾病研究研究
背景情况:
- 失眠 (ISM) 是动脉样硬化 (AS) 的新兴风险因素.
- 了解ISM和AS之间的分子联系对于心血管健康至关重要.
- 本研究调查了与ISM相关的AS的共享途径和生物标志物.
研究的目的:
- 为了确定失眠和动脉样硬化之间的共同基因和途径.
- 发现失眠相关动脉样硬化症的新型诊断生物标志物.
- 探索潜在的免疫和炎症机制.
主要方法:
- 公共数据集的综合生物信息学分析 (GEO,GeneCards).
- 权重基因共同表达网络分析和差异性基因表达分析.
- 蛋白质与蛋白质相互作用网络的构建和用于生物标记物识别的机器学习.
主要成果:
- 在失眠和动脉样硬化之间确定了61个共享基因.
- 发现了三个诊断生物标志物:IL10RA,CCR1和SPI1.
- 开发了一种具有高预测精度 (AUC=0.931) 的名图,用于ISM相关的AS.
结论:
- IL10RA,CCR1和SPI1是失眠相关动脉样硬化的潜在诊断生物标志物.
- 共享的基因在免疫和炎症途径中得到丰富.
- 研究结果提供了对ISM相关AS的早期诊断和治疗策略的见解.
相关概念视频
Genome-wide Association Studies-GWAS
12.6K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
12.6K
Coronary Artery Disease I: Introduction
3
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
3


